Human inherited CCR2 deficiency underlies progressive polycystic lung disease
Archive ouverte
Neehus, Anna-Lena | Carey, Brenna | Landekic, Marija | Panikulam, Patricia | Deutsch, Gail | Ogishi, Masato | Arango-Franco, Carlos A. | Philippot, Quentin | Modaresi, Mohammadreza | Mohammadzadeh, Iraj | Corcini Berndt, Melissa | Rinchai, Darawan | Le Voyer, Tom | Rosain, Jérémie | Momenilandi, Mana | Martin-Fernandez, Marta | Khan, Taushif | Bohlen, Jonathan | Han, Ji Eun | Deslys, Alexandre | Bernard, Mathilde | Gajardo-Carrasco, Tania | Soudée, Camille | Le Floc’h, Corentin | Migaud, Mélanie | Seeleuthner, Yoann | Jang, Mi-Sun | Nikolouli, Eirini | Seyedpour, Simin | Begueret, Hugues | Emile, Jean-François | Le Guen, Pierre | Tavazzi, Guido | Colombo, Costanza Natalia Julia | Marzani, Federico Capra | Angelini, Micol | Trespidi, Francesca | Ghirardello, Stefano | Alipour, Nasrin | Molitor, Anne | Carapito, Raphaël | Mazloomrezaei, Mohsen | Rokni-Zadeh, Hassan | Changi-Ashtiani, Majid | Brouzes, Chantal | Vargas, Pablo | Borghesi, Alessandro | Lachmann, Nico | Bahram, Seiamak | Crestani, Bruno | Fayon, Michael | Galode, François | Pahari, Susanta | Schlesinger, Larry S. | Marr, Nico | Bogunovic, Dusan | Boisson-Dupuis, Stéphanie | Béziat, Vivien | Abel, Laurent | Borie, Raphael | Young, Lisa R. | Deterding, Robin | Shahrooei, Mohammad | Rezaei, Nima | Parvaneh, Nima | Craven, Daniel | Gros, Philippe | Malo, Danielle | Sepulveda, Fernando E. | Nogee, Lawrence M. | Aladjidi, Nathalie | Trapnell, Bruce C. | Casanova, Jean-Laurent | Bustamante, Jacinta
Edité par
CCSD ; Elsevier -
We describe a human lung disease caused by autosomal recessive, complete deficiency of the monocyte chemokine receptor C-C motif chemokine receptor 2 (CCR2). Nine children from five independent kindreds have pulmonary alveolar proteinosis (PAP), progressive polycystic lung disease, and recurrent infections, including bacillus Calmette Guérin (BCG) disease. The CCR2 variants are homozygous in six patients and compound heterozygous in three, and all are loss-of-expression and loss-of-function. They abolish CCR2-agonist chemokine C-C motif ligand 2 (CCL-2)-stimulated Ca2+ signaling in and migration of monocytic cells. All patients have high blood CCL-2 levels, providing a diagnostic test for screening children with unexplained lung or mycobacterial disease. Blood myeloid and lymphoid subsets and interferon (IFN)-γ- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-mediated immunity are unaffected. CCR2-deficient monocytes and alveolar macrophage-like cells have normal gene expression profiles and functions. By contrast, alveolar macrophage counts are about half. Human complete CCR2 deficiency is a genetic etiology of PAP, polycystic lung disease, and recurrent infections caused by impaired CCL2-dependent monocyte migration to the lungs and infected tissues.
